Although further studies of these transcripts may reveal important information about the pathology of SA treatment and EMT progression in somatotroph adenomas, only RORC was associated with tumor size prior to SA treatment, as well as tumor reduction and IGF-I reduction following SA treatment, both in the univariate and multiple analyses. The gene discussed is RORC; the disease is growth hormone-secreting pituitary adenoma.